Patents by Inventor Pravin Kaumaya
Pravin Kaumaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9452204Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: GrantFiled: May 30, 2013Date of Patent: September 27, 2016Assignee: Ohio State Innovation FoundationInventor: Pravin Kaumaya
-
Publication number: 20140010831Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: ApplicationFiled: May 30, 2013Publication date: January 9, 2014Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATIONInventor: Pravin Kaumaya
-
Publication number: 20130230546Abstract: Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer, are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.Type: ApplicationFiled: May 3, 2013Publication date: September 5, 2013Inventors: Pravin Kaumaya, David Cohn
-
Patent number: 8470333Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: GrantFiled: February 1, 2010Date of Patent: June 25, 2013Assignee: The Ohio State University Research FoundationInventor: Pravin Kaumaya
-
Publication number: 20120201841Abstract: Compositions for stimulating the immune system and for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include immunogenic epitopes of the HER-2 proteins and chimeric and multivalent peptides which comprise such epitopes. The present invention also relates to polynucleotides which encode the chimeric peptides. Also provided are pharmaceutical compositions comprising such immunogenic compositions. Methods for stimulating an immune response to HER-2 protein are provided. Methods for treating breast cancer, ovarian cancer, prostate cancer, colon cancer and lung cancer are provided.Type: ApplicationFiled: February 6, 2012Publication date: August 9, 2012Applicant: THE OHIO STATE UNIVERSITYInventor: PRAVIN KAUMAYA
-
Publication number: 20120121626Abstract: Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.Type: ApplicationFiled: December 20, 2011Publication date: May 17, 2012Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATIONInventors: Pravin Kaumaya, David Cohn
-
Patent number: 8110657Abstract: Compositions for stimulating the immune system and for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include immunogenic epitopes of the HER-2 proteins and chimeric and multivalent peptides which comprise such epitopes. The present invention also relates to polynucleotides which encode the chimeric peptides. Also provided are pharmaceutical compositions comprising such immunogenic compositions. Methods for stimulating an immune response to HER-2 protein are provided. Methods for treating breast cancer, ovarian cancer, prostate cancer, colon cancer and lung cancer are provided.Type: GrantFiled: January 6, 2010Date of Patent: February 7, 2012Assignee: The Ohio State UniversityInventor: Pravin Kaumaya
-
Patent number: 8080253Abstract: Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.Type: GrantFiled: February 7, 2005Date of Patent: December 20, 2011Assignee: The Ohio State University Research FoundationInventors: Pravin Kaumaya, David Cohn
-
Publication number: 20110086055Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: ApplicationFiled: February 1, 2010Publication date: April 14, 2011Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATIONInventor: Pravin Kaumaya
-
Publication number: 20100234283Abstract: Provided herein are compositions and methods for the treatment of cancers. The compositions comprise at least one VEGF peptide mimic, HER-2 epitope, immunogenic VEGF peptides, and HER-2 immunogenic epitopes. The peptides and epitopes may be linear, cyclized, retro-inverso, or a combination of such forms. Also provided herein are antibodies raised to VEGF peptide mimics, HER-2 epitopes, immunogenic VEGF peptides, and HER-2 immunogenic epitopes.Type: ApplicationFiled: February 4, 2010Publication date: September 16, 2010Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATIONInventor: Pravin Kaumaya
-
Publication number: 20100112071Abstract: Compositions for stimulating the immune system and for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include immunogenic epitopes of the HER-2 proteins and chimeric and multivalent peptides which comprise such epitopes. The present invention also relates to polynucleotides which encode the chimeric peptides. Also provided are pharmaceutical compositions comprising such immunogenic compositions. Methods for stimulating an immune response to HER-2 protein are provided. Methods for treating breast cancer, ovarian cancer, prostate cancer, colon cancer and lung cancer are provided.Type: ApplicationFiled: January 6, 2010Publication date: May 6, 2010Applicant: THE OHIO STATE UNIVERSITYInventor: Pravin Kaumaya
-
Patent number: 7691396Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: GrantFiled: June 15, 2006Date of Patent: April 6, 2010Assignee: The Ohio State University Research FoundationInventor: Pravin Kaumaya
-
Publication number: 20070243206Abstract: The present invention provides synthetic chimeric fimbrin peptides which induce an immunogenic response in animals to non-typable Haemophilus influenzae and that do not require tedious purification techniques. The synthetic chimeric fimbrin peptides reduce the severity of otitis media caused by Haemophilus influenzae. The synthetic chimeric fimbrin peptides are synthesized using commercially available peptide synthesizers. The synthetic chimeric fimbrin peptides comprises three peptide units. The first peptide unit is a subunit of the fimbrin protein. Preferably, the fimbrin subunit is comprised of the amino acids of Sequence ID No. 1 or Sequence ID No. 2. The second peptide unit is a t cell epitope, and preferably has the amino acid sequence of SEQ ID NO. 3. The third peptide unit is a linker peptide unit which joins the first and second peptide unit.Type: ApplicationFiled: May 7, 2007Publication date: October 18, 2007Applicant: The Ohio State UniversityInventors: Lauren Bakaletz, Pravin Kaumaya
-
Publication number: 20070071827Abstract: Compositions for stimulating the immune system and for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include immunogenic epitopes of the HER-2 proteins and chimeric and multivalent peptides which comprise such epitopes. The present invention also relates to polynucleotides which encode the chimeric peptides. Also provided are pharmaceutical compositions comprising such immunogenic compositions. Methods for stimulating an immune response to HER-2 protein are provided. Methods for treating breast cancer, ovarian cancer, prostate cancer, colon cancer and lung cancer are provided.Type: ApplicationFiled: June 9, 2006Publication date: March 29, 2007Applicant: THE OHIO STATE UNIVERSITYInventors: Pravin Kaumaya, Vernon Stevens, Pierre Triozzi
-
Publication number: 20070060516Abstract: Compositions, methods, and vaccines that may stimulate the immune system and that may be used for treating malignancies associated with overexpression of the HER-2 protein are provided. Such compositions include epitopes of the HER-2 proteins.Type: ApplicationFiled: June 15, 2006Publication date: March 15, 2007Applicant: The Ohio State University Research FoundationInventors: Pravin Kaumaya, Joan Steele, Stephanie Allen, Rawale Sharad
-
Publication number: 20050233964Abstract: Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer.Type: ApplicationFiled: February 7, 2005Publication date: October 20, 2005Inventors: Pravin Kaumaya, David Cohn